This spring, Life After ECT launched a comprehensive FDA reporting guide for injured electroconvulsive therapy (ECT) recipients. This post is a progress update and an overview of our future reporting goals.
A study exploring immune response to electroconvulsive therapy and its impact on white matter microstructure of the brain.
A response to yet another defence of ECT in the absence of robust efficacy and safety evidence by Professor John Read
Prominent ECT proponent Max Fink, a says ECT patients are mistreated by researchers in an interview on the comeback of electroshock.
Many barriers keep people harmed by ECT from reporting their injuries to the FDA. This comprehensive guide explains what adverse medical event reporting is and walks you through the process.
These are reports from people who had ECT in recent years and experienced permanent deficits in memory ability and other cognitive abilities (known as anterograde amnesia).